Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Pfizer Inc (NYSE:PFE)

34.61
Delayed Data
As of May 27
 +0.18 / +0.52%
Today’s Change
28.25
Today|||52-Week Range
36.46
+7.22%
Year-to-Date
Bet You Can't Guess Which of These 10 Big Pharma Names Has the Largest Late-Stage Pip...
2:18pm / MotleyFool.com - Paid Partner Content
Sanofi Diabetes Drugs Briefing Documents Raise Concerns
May 24 / Zacks.com - Paid Partner Content
Portola Pharmaceuticals: Does New Data Get It Back on Track?
9:42am / MotleyFool.com - Paid Partner Content
Intermediate Trade: International Paper
May 24 / TheStreet.com - Paid Partner Content
This New Data Could Push Exelixis' Cabometyx Over $1 Billion in Peak Annual Sales
May 27 / MotleyFool.com - Paid Partner Content
Billionaires Lightened Their Load on These 3 Widely-Held Stocks in Q1
May 24 / MotleyFool.com - Paid Partner Content
3 Small Biotechs That Look Very Healthy
May 27 / TheStreet.com - Paid Partner Content
Allergan to do Smaller Deals and Boost Credit Rating
May 23 / TheStreet.com - Paid Partner Content
Interested in Medivation? Take a Number!
May 27 / MotleyFool.com - Paid Partner Content
Why JANA's Flight From Walgreens Is a Big Deal ... for JANA
May 23 / TheStreet.com - Paid Partner Content
Flexion (FLXN) Zilretta Gets Positive FDA Guidance; Stock Up
May 27 / Zacks.com - Paid Partner Content
Pfizer (PFE) Stock Closed Down, European Drug Warning Lifted
May 23 / TheStreet.com - Paid Partner Content
Minerva Surges on Positive Results on Depression Candidate
May 27 / Zacks.com - Paid Partner Content
Pfizer's (PFE) Trumenba Accepted for Review in the EU
May 23 / Zacks.com - Paid Partner Content
Dow 30 Stock Roundup: Boeing Wins $11.3B Contract, GE to Invest $3B in Saudi Arabia
May 26 / Zacks.com - Paid Partner Content
Stock Market News for May 23, 2016
May 23 / Zacks.com - Paid Partner Content
Innocoll Stock Gains on Favorable Phase III Data on Xaracoll
May 26 / Zacks.com - Paid Partner Content
Bayer to Buy Monsanto for $62B to Boost Agriculture Portfolio
May 23 / Zacks.com - Paid Partner Content
Cancer Immunotherapies Take Center Stage in Pre-ASCO Abstract Releases
May 26 / MotleyFool.com - Paid Partner Content
CF Industries Pulls $8B Takeover of OCI Assets
May 23 / TheStreet.com - Paid Partner Content
Applied Materials, Agrium, Pfizer and KB Home highlighted as Zacks Bull and Bear of t...
May 26 / Zacks.com - Paid Partner Content
3 Stocks Senior Citizens Could Buy Now
May 22 / MotleyFool.com - Paid Partner Content
Buy Pfizer, Chevron, Newell Brands and Enjoy the Profits
May 25 / TheStreet.com - Paid Partner Content
Here's What Pfizer's Telling Us About Biotech M&A
May 21 / MotleyFool.com - Paid Partner Content
Top Stock Picks for the Week of May 23rd
May 25 / Zacks.com - Paid Partner Content
Merrimack/Baxalta Start Study on Colorectal Cancer Drug
May 20 / Zacks.com - Paid Partner Content
PDL BioPharma Agrees to Equity Investment in Noden Pharma
May 25 / Zacks.com - Paid Partner Content
Dow 30 Stock Roundup: Wal-Mart, Home Depot Beat, Cisco Earnings In Line
May 20 / Zacks.com - Paid Partner Content
Biodel/Albireo Limited to Combine; Focus on Liver Diseases
May 25 / Zacks.com - Paid Partner Content
Merck KGaA's Q1 Earnings Increase Y/Y, Offers 2016 View
May 20 / Zacks.com - Paid Partner Content
Lilly's (LLY) R&D Update, Targets 20 New Launches by 2023
May 25 / Zacks.com - Paid Partner Content
US companies' cash pile hits $1.7tn
May 20 / FT.com - Paid Partner Content
Billionaires are Dumping These 3 Stocks
May 25 / MotleyFool.com - Paid Partner Content
Roche Gets Accelerated Approval for Immunotherapy Drug
May 19 / Zacks.com - Paid Partner Content
Billionaires Are Bailing on Pfizer, Inc -- Should You?
May 24 / MotleyFool.com - Paid Partner Content
Why Spark Therapeutics Caught Fire and Rallied Higher Today
May 19 / MotleyFool.com - Paid Partner Content
Pfizer's Buyout of Anacor Pharmaceuticals for $5.2 Billion Is a Bad Move -- Here's Wh...
May 24 / MotleyFool.com - Paid Partner Content
Novartis (NVS) to Stop Trial on Breast Cancer Drug Early
May 18 / Zacks.com - Paid Partner Content
Xenoport to be Acquired by Arbor Pharmaceuticals; Stock Up
May 24 / Zacks.com - Paid Partner Content
Bear of the Day: AbbVie (ABBV)
May 18 / Zacks.com - Paid Partner Content
Pfizer Wants to Be Seen as an Oncology Powerhouse
May 24 / TheStreet.com - Paid Partner Content
Catalyst (CPRX) Resorts to Layoffs for Firdapse Development
May 18 / Zacks.com - Paid Partner Content
4 Dow Members Bucking the Negative Trend
May 24 / Zacks.com - Paid Partner Content
Biotech ETFs Soar on Pfizer-Anacor Deal: SBIO, XBI in Lead
May 17 / Zacks.com - Paid Partner Content
Pfizer Champix's Label to Include More Data, Warning Lifted
May 24 / Zacks.com - Paid Partner Content
Aegerion (AEGR) Misses Q1 Earnings Estimates, Cuts View
May 17 / Zacks.com - Paid Partner Content
The Best Buys in Biopharma Today
May 24 / MotleyFool.com - Paid Partner Content
Pfizer to Buy Anacor, Add Eczema Treatment to Portfolio
May 17 / Zacks.com - Paid Partner Content
CF Industries Ends $8B OCI Deal Due to Tax Inversion Rules
May 24 / Zacks.com - Paid Partner Content
Apple Inc. and Anacor Pharmaceuticals Inc. Soar As Stocks Jump
May 16 / MotleyFool.com - Paid Partner Content